Enanta Pharmaceuticals, Inc’s publication on the International Journal of Gastroenterology.
SMC announces that Enanta Pharmaceuticals, Inc. has published the results of a study using the STAM™ model in the International Journal of Gastroenterology.
Title: Characterization of EDP-305, a Highly Potent and Selective Farnesoid X Receptor Agonist, for the Treatment of Non-alcoholic Steatohepatitis
Read more…. http://www.sciencepublishinggroup.com/journal/paperinfo?journalid=282&doi=10.11648/j.ijg.20190301.12